Allison Winter

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson et al. · Haematologica · 2018 · 439 citations · Full text

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

Anthony R. Mato, Brian T. Hill, Nicole Lamanna et al. · Annals of Oncology · 2017 · 219 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Optimal Sequencing +11

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States

Anthony R. Mato, Meghan C. Thompson, John N. Allan et al. · Haematologica · 2018 · 161 citations · Full text

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

Lindsey E. Roeker, Christopher P. Fox, Toby A. Eyre et al. · Clinical Cancer Research · 2019 · 89 citations · Full text

Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML)

Bernard Tawfik, Timothy S. Pardee, Scott Isom et al. · Journal of Geriatric Oncology · 2015 · 62 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +7